In ovarian cancer cells, abnormal elevation of PDK1 can upregulate programmed death ligand-1 (PD-L1) expression and induce increased apoptosis of CD8+ T cells, ultimately impairing T cell immune function (80). Here, CD8A is linked to ovarian carcinoma.